Pantoflux (Pantoprazole Sodium)

Pantoprazole, the active ingredient in Pantoflux, is a proton pump inhibitor presented as an oral tablet for gastroenteral use. It reduces gastric acid secretion and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Pantoflux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Its global logistics network ensures timely delivery to diverse healthcare settings.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing gastric acid exposure to the esophagus. - Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions and prevents recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Pantoprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild, transient pain often reported during treatment. - Diarrhea: loose stools that may occur early in therapy. - Nausea: feeling of queasiness without vomiting. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Liver enzyme elevation: signs of hepatic injury such as jaundice. - Stevens‑Johnson syndrome: serious skin disorder with blistering. - Pancreatitis: inflammation of the pancreas causing upper abdominal pain. - Hypomagnesemia: low magnesium levels with prolonged use.

Before initiating Pantoflux, clinicians should consider several safety precautions to minimize risk. - Assess renal function: adjust therapy in patients with severe impairment. - Monitor magnesium levels: prolonged treatment may lead to hypomagnesemia. - Review concomitant medications: avoid or adjust drugs that interact significantly. - Use caution in hepatic disease: monitor liver function tests during therapy. - Store at room temperature: keep in the original container, protect from moisture.

Pantoflux can affect, or be affected by, other medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Ketoconazole: reduced absorption of the antifungal. - Atazanavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet activation.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR and bleeding risk. - Methotrexate: elevated serum concentrations may occur. - Digoxin: potential rise in serum digoxin levels.